Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      ERT Reports Third Quarter 2011 Operating Results

      - Record revenues of $48.1 million

      - Diluted net income per share - GAAP of $0.09 / Non-GAAP of $0.11

      - Record bookings of $78.4 million

      - Record backlog of $343.8 million


      News provided by

      ERT

      Oct 27, 2011, 04:05 ET

      Share this article

      Share this article


      PHILADELPHIA, Oct. 27, 2011 /PRNewswire/ -- eResearchTechnology, Inc. (ERT), (Nasdaq: ERT) a global technology-driven provider of services and customizable medical devices to biopharmaceutical and healthcare organizations and the market leader for centralized cardiac safety and respiratory efficacy services in drug development, announced today results for the third quarter ended September 30, 2011.  Unless otherwise noted, all comparative numbers refer to changes from the same period a year ago.  The financial results include the results related to CareFusion Research Services (RS and now included as part of our German operations) commencing from its date of acquisition on May 28, 2010.  

      This press release contains financial measures prepared in accordance with accounting principles generally accepted in the United States ("GAAP") and non-GAAP measures adjusted to exclude the impact of the amortization of the acquired intangibles and other assets and acquisition and other costs related to the RS acquisition and related income tax effects.  A reconciliation of these GAAP and non-GAAP measures is found in the attached "Reconciliation of GAAP to Non-GAAP Information."

      Financial Highlights for the Third Quarter of 2011

      • New bookings were $78.4 million in the third quarter of 2011 compared to $70.9 million for the second quarter of 2011 and $59.1 million a year ago.  
      • The gross book-to-bill ratio was 1.6 in the third quarter of 2011 compared to 1.7 in the second quarter of 2011 and 1.3 a year ago.  
      • Backlog was $343.8 million as of September 30, 2011 compared to $333.2 million as of June 30, 2011 and $303.1 million a year ago.  The annualized cancellation rate was 14.6% in the third quarter of 2011 compared to 13.4% in the second quarter of 2011 and 14.6% a year ago.  
      • Net revenues were $48.1 million for the third quarter of 2011 compared to $42.8 million for the second quarter of 2011 and $45.1 million a year ago.  Revenues from our German operations were $24.1 million in the third quarter of 2011, compared to $20.3 million in the second quarter of 2011 and $21.5 million a year ago.
      • GAAP gross margin percentage was 41.5% in the third quarter of 2011 compared to 37.4% for the second quarter of 2011 and 44.5% a year ago.  Non-GAAP gross margin percentage was 45.5% in the third quarter of 2011 compared to 42.0% for the second quarter of 2011 and 50.0% a year ago.  Our gross profit margin in the second quarter of 2011 was unusually low due to increased costs in our German operations to support the start of new respiratory studies, negative manufacturing variances and a $0.5 million non-cash adjustment to the carrying value of returned rental equipment.  Gross margins are down from a year ago due to the increased mix of lower margin respiratory revenue.  
      • GAAP operating income margin percentage was 10.9% in the third quarter of 2011 compared to 6.0% for the second quarter of 2011 and 14.6% a year ago.  Non-GAAP operating income margin percentage was 14.9% in the third quarter of 2011 compared to 10.6% for the second quarter of 2011 and 21.3% a year ago.
      • GAAP net income was $4.3 million, or $0.09 per diluted share, in the third quarter of 2011 compared to $1.8 million, or $0.04 per diluted share, in the second quarter of 2011 and $3.2 million, or $0.06 per diluted share, a year ago.  Non-GAAP net income was $5.6 million, or $0.11 per diluted share, in the third quarter of 2011 compared to $3.0 million, or $0.06 per diluted share, in the second quarter of 2011 and $5.4 million, or $0.11 per diluted share, a year ago.  The impact of foreign exchange rate movements on GAAP and non-GAAP diluted net income per share was a positive $0.01 in the third quarter of 2011 and a negative of $0.03 a year ago.
      • Cash flow from operations was $9.2 million in the third quarter of 2011, compared to $8.7 million in the second quarter of 2011 and $6.4 million a year ago.
      • Cash and short-term investments totaled $29.6 million at September 30, 2011 compared to $31.7 million on June 30, 2011.  ERT had $21.0 million in long-term debt as of September 30, 2011 and June 30, 2011.
      • Capital expenditures were $10.2 million for the third quarter of 2011, up sequentially from $7.5 million in the second quarter of 2011 and were comprised of $4.4 million of capitalized software and $5.8 million of equipment which primarily included additions to our rental equipment pool of ECG, respiratory and ePRO equipment to support new studies.  

      Financial highlights for the first nine months of 2011

      • New bookings were $221.0 million in the first nine months of 2011 compared to $153.3 million for the first nine months of 2010.  
      • Net revenues were $132.6 million for the first nine months of 2011 compared to $96.1 million in the comparable period a year ago.  Revenues from our German operations were $63.3 million for the first nine months of 2011 and $27.2 million from the period of acquisition to September 30, 2010.
      • GAAP gross margin percentage was 41.0% in the first nine months of 2011 compared to 49.6% for the comparable period a year ago.  Non-GAAP gross margin percentage was 45.4% in the first nine months of 2011 compared to 53.0% for the comparable period a year ago.
      • GAAP operating income margin percentage was 9.9% in the first nine months of 2011 compared to 10.8% in the comparable period a year ago.  Non-GAAP operating income margin percentage was 14.3% in the first nine months of 2011 compared to 19.6% for the comparable period a year ago.   
      • GAAP net income was $9.2 million, or $0.19 per diluted share, in the first nine months of 2011 compared to $5.8 million, or $0.12 per diluted share, in the comparable period a year ago.  Non-GAAP net income was $13.1 million, or $0.27 per diluted share, in the first nine months of 2011 compared to $12.3 million, or $0.25 per diluted share, in the comparable period a year ago.  
      • Cash flow from operations was $22.9 million in the first nine months of 2011 compared to $18.8 million in the comparable period a year ago.

      "We are pleased with the third quarter results which included both record revenues and bookings." commented Dr. Jeffrey Litwin, President and Chief Executive Officer of ERT.  "This quarter marks the third consecutive quarter that bookings exceeded $70 million.  The bookings this quarter were driven by continued strength in electronic Patient Reported Outcome (ePRO) and very strong cardiac safety activity.  While the revenues came in at the higher end of our expectations and our gross profit margins improved sequentially, our profitability was impacted by a mix shift from higher margin cardiac safety revenue to lower margin respiratory revenue and increased costs for bonus provisions and expansion of our facility in Germany to accommodate higher growth which resulted in achieving EPS at the lower end of our expectations."  

      "We continue to see interest in the unique solutions we can provide to our clients," continued Dr. Litwin, "and this is translating to record bookings at a time where overall research and development  spending is relatively flat.  We will continue to invest in the products that differentiate us from the competition.  We expect our fourth quarter results to be fairly similar to the third quarter, resulting in higher second half 2011 revenues and bookings as compared to the first half of the year.  The growth in our respiratory business has required us to incur higher spending in cost of goods, operating expense and capital expenditures than we had originally planned.  We are, however, seeing the results of our efforts in our revenue growth and we expect our profit margins to improve over the course of 2012 as the strategic initiatives we put in place today take hold, our Germany operations reach a steady state of profitability and we launch our fully-integrated EXPERT 3 platform.

      2011 Guidance

      ERT expects net revenues of between $179 million and $182 million for 2011.  ERT expects GAAP diluted net income per share to be between $0.25 and $0.28 for 2011 and non-GAAP diluted net income per share to be between $0.35 and $0.38 for the same period.  EPS guidance has been reduced to reflect a mix shift from higher margin cardiac safety revenue to lower margin respiratory revenue, a steady state level of operating expenses and limited impact of foreign exchange (which had a positive impact of $0.01 per diluted share on our third quarter 2011 results).

      For the fourth quarter ending December 31, 2011, we expect revenues to be between $46 million and $49 million, GAAP diluted net income per share to be between $0.06 and $0.09 and non-GAAP diluted net income per share to be between $0.08 and $0.11.

      Use of Non-GAAP Financial Measures

      In addition to GAAP financial measures, ERT uses certain non-GAAP financial measures that exclude charges related to the amortization of the RS acquired intangible and other assets and acquisition and other costs which are related to the RS acquisition, and also their related income tax effects.  ERT believes that these non-GAAP measures are useful to investors because this supplemental information facilitates comparisons of its operations from period to period and to the performance of other companies within its industry and assists in gaining a better understanding of its operating results and future prospects.  ERT views amortization of acquired intangible and other assets related to the RS acquisition, which includes such items as the amortization of acquired customer backlog and technology, as items determined at the time of the acquisition.  While ERT reviews the underlying value of these intangibles regularly for impairment, the amortization is an expense typically not affected by operations during any particular period and does not contribute to the operational performance in any particular period.  ERT regards acquisition and other costs related to its recent acquisition as a cost that does not recur on a regular basis.  

      ERT's non-GAAP effective tax rates differ from its GAAP effective tax rates because of 1) the exclusion of the amortization of acquired intangible and other assets and acquisition and other costs related to its acquisition of RS and 2) the income tax effect due to the difference between the GAAP and non-GAAP effective tax rate applied against the GAAP pre-tax income, primarily as a result of the acquisition costs incurred in 2010 not being deductible for income tax purposes.  ERT excludes the impact of these discrete tax items from its non-GAAP income tax provision because it believes they are not indicative of the effective income tax rate of its ongoing business operations.

      Management uses these non-GAAP financial measures, in addition to the measures prepared in accordance with GAAP, as the basis for measuring ERT's operating performance, financial and operating decision-making, developing budgets and comparing such performance to that of prior periods for the same reasons stated above.  These non-GAAP financial measures are not meant to be considered superior to or a substitute for comparable financial measures prepared in accordance with GAAP.  There are also limitations on the non-GAAP measures, including: 1) these non-GAAP measures do not have standardized meanings and may not be comparable to similar non-GAAP measures used by other companies, 2) acquisition and other costs related to ERT's 2010 acquisition of RS represent actual cash expenditures that are excluded from ERT's non-GAAP measures and 3) although amortization of acquired intangible and other assets does not directly impact ERT's current cash position, such expense is amortized over their expected economic lives and does represent the declining value of the assets acquired, but this expense is excluded from ERT's non-GAAP measures.  ERT adjusts for these limitations by relying on these non-GAAP measures only as a supplement to its GAAP results.

      Conference Call

      Dr. Litwin and Mr. Keith Schneck, the Company's Chief Financial Officer, will hold a conference call to discuss these results.  The conference call will take place at 5:00 PM EDT on October 27, 2011.  For the conference call, interested participants should dial 1-800-860-2442 when calling within the United States or 1-412-858-4600 when calling internationally.  There will be a playback available as well.  To listen to the playback, please call 1-877-344-7529 when calling within the United States or 1-412-317-0088 when calling internationally.  Conference code for playback is 10005603.

      This call is being webcast by MultiVu and can be accessed at ERT's website at www.ert.com.  The webcast may also be accessed via the direct link at http://www.videonewswire.com/event.asp?id=82965.  The webcast can be accessed for up to one year on either site.  

      About eResearchTechnology, Inc.

      ERT (www.ert.com) is a global technology-driven provider of clinical services and customizable medical devices to biopharmaceutical and healthcare organizations.  It is the market leader for centralized cardiac safety and respiratory efficacy services in drug development and also collects, analyzes and distributes electronic patient reported outcomes (ePRO) in multiple modalities across all phases of clinical research.

      This release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that reflect our current views as to future events and financial performance with respect to our operations.  These statements can be identified by the fact that they do not relate strictly to historical or current facts.  They use words such as "aim," "anticipate," "are confident," "estimate," "expect," "will be," "will continue," "will likely result," "project," "intend," "plan," "believe," "look to" and other words and terms of similar meaning in conjunction with a discussion of future operating or financial performance.  

      These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied in the forward-looking statements.  Factors that might cause such a difference include: unfavorable economic conditions; our ability to obtain new contracts and accurately estimate net revenues, our positive outlook for future bookings, variability in size, scope and duration of projects and internal issues at the sponsoring client; our ability to successfully integrate the RS or any future acquisitions; competitive factors in the market for our centralized services; changes in the bio-pharmaceutical and healthcare industries to which we sell our solutions; technological development; and market demand.  There is no guarantee that the amounts in our backlog will ever convert to revenue.  Should the economic conditions deteriorate, the cancellation rates that we have historically experienced could increase.  Further information on potential factors that could affect the Company's financial results can be found in ERT's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission.  Guidance is based on management's good faith expectations given current market conditions but that continued or further deterioration of general economic conditions, in addition to other factors cited elsewhere, could result in ERT not achieving the revenue and net income per diluted share guidance provided.

      Forward-looking statements speak only as of the date made.  We undertake no obligation to update any forward-looking statements, including prior forward-looking statements, to reflect the events or circumstances arising after the date as of which they were made.  As a result of these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements included in this release or that may be made in our filings with the Securities and Exchange Commission or elsewhere from time to time by, or on behalf of, us.

      Contact:


      Keith Schneck

      Robert East

      eResearchTechnology, Inc.

      Westwicke Partners, LLC

      215-282-5566

      443-213-0502



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Statements of Operations

      (in thousands, except per share amounts)

      (unaudited)





















      Three Months Ended September 30,




      Nine Months Ended September 30,





      2010



      2011




      2010



      2011













      Net revenues:















      Services



      $          25,929



      $          25,193




      $          59,461



      $         71,586


      Site support



      19,199



      22,890




      36,631



      61,045
















      Total net revenues



      45,128



      48,083




      96,092



      132,631
















      Costs of revenues:















      Cost of services



      13,526



      14,554




      29,162



      41,325


      Cost of site support



      11,505



      13,574




      19,261



      36,886
















      Total costs of revenues



      25,031



      28,128




      48,423



      78,211
















      Gross margin



      20,097



      19,955




      47,669



      54,420
















      Operating expenses:















      Selling and marketing



      4,478



      4,683




      11,827



      13,284


      General and administrative



      7,780



      8,141




      22,278



      22,896


      Research and development



      1,250



      1,898




      3,177



      5,083
















      Total operating expenses



      13,508



      14,722




      37,282



      41,263
















      Operating income



      6,589



      5,233




      10,387



      13,157

      Foreign exchange (losses) gains



      (1,745)



      695




      (1,267)



      (580)

      Other (expense) income, net



      (199)



      (125)




      (181)



      (394)
















      Income before income taxes



      4,645



      5,803




      8,939



      12,183

      Income tax provision



      1,472



      1,476




      3,188



      2,982
















      Net income



      $            3,173



      $            4,327




      $            5,751



      $           9,201
















      Net income per share:















      Basic



      $              0.06



      $              0.09




      $              0.12



      $             0.19


      Diluted



      $              0.06



      $              0.09




      $              0.12



      $             0.19
















      Shares used in computing net income per share:















      Basic



      48,860



      49,234




      48,789



      49,092


      Diluted



      49,258



      49,311




      49,162



      49,297



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Balance Sheets

      (in thousands, except share and per share amounts)

      (unaudited)



















      December 31, 2010


      September 30, 2011

      ASSETS
















      Current assets:








          Cash and cash equivalents



      $                30,343




      $               29,535

          Short-term investments



      50




      50

          Investment in marketable securities



      648




      810

          Accounts receivable less allowance for doubtful accounts








               of $515 and $549, respectively



      37,236




      40,456

          Inventory



      4,698




      10,591

          Prepaid income taxes



      1,988




      2,091

          Prepaid expenses and other



      4,393




      5,294

          Deferred income taxes



      3,431




      3,548

              Total current assets



      82,787




      92,375









      Property and equipment, net



      42,615




      51,761

      Goodwill



      71,637




      75,230

      Intangible assets



      17,187




      13,080

      Other assets



      609




      691









                 Total assets



      $              214,835




      $             233,137









      LIABILITIES AND STOCKHOLDERS' EQUITY
















      Current liabilities:








          Accounts payable



      $                  7,136




      $                 6,147

          Accrued expenses



      16,162




      14,105

          Deferred revenues



      11,670




      13,599

              Total current liabilities



      34,968




      33,851









      Deferred rent



      2,368




      2,450

      Deferred income taxes



      3,703




      4,727

      Long-term debt



      21,000




      21,000

      Other liabilities



      2,141




      1,998









                 Total liabilities



      64,180




      64,026









      Stockholders' equity:








          Preferred stock-$10.00 par value, 500,000 shares authorized,








               none issued and outstanding



      -




      -

          Common stock-$.01 par value, 175,000,000 shares authorized,








               60,460,782 and 60,837,849 shares issued, respectively



      605




      608

          Additional paid-in capital



      100,441




      103,487

          Accumulated other comprehensive (loss) income



      (1,545)




      4,707

          Retained earnings



      131,037




      140,238

          Treasury stock, 11,589,603 and 11,596,966 shares at cost



      (79,883)




      (79,929)









              Total stockholders' equity



      150,655




      169,111









                 Total liabilities and stockholders' equity



      $              214,835




      $             233,137



      eResearchTechnology, Inc. and Subsidiaries

      Consolidated Statements of Cash Flows

      (in thousands)

      (unaudited)






      Nine Months Ended September 30,





      2010


      2011








      Operating activities:







        Net income




      $           5,751


      $           9,201

        Adjustments to reconcile net income to net cash







            provided by operating activities:







                Depreciation and amortization




      12,753


      19,202

                Cost of sales of equipment




      767


      14

                Share-based compensation




      2,048


      2,151

                Deferred income taxes




      (1,043)


      912

                Loss on disposal of equipment




      -


      862

                Changes in operating assets and liabilities:







                   Accounts receivable




      (6,429)


      (2,966)

                   Inventory




      (984)


      (4,331)

                   Prepaid expenses and other




      (640)


      (1,185)

                   Accounts payable




      1,622


      (668)

                   Accrued expenses




      5,145


      (2,096)

                   Income taxes




      (1,125)


      (112)

                   Deferred revenues




      1,153


      1,882

                   Deferred rent




      (225)


      75

                       Net cash provided by operating activities




      18,793


      22,941








      Investing activities:







        Purchases of property and equipment




      (15,987)


      (24,964)

        Purchases of investments




      (999)


      -

        Proceeds from sales of investments




      10,731


      -

        Payments for acquisitions




      (82,789)


      (117)

                       Net cash used in investing activities




      (89,044)


      (25,081)








      Financing activities:







        Proceeds from long-term debt




      23,000


      -

        Repayment of long-term debt




      (2,000)


      -

        Proceeds from exercise of stock options




      215


      771

        Stock option income tax benefit




      29


      17

        Repurchase of common stock for treasury




      -


      (46)

                       Net cash provided by financing activities




      21,244


      742








      Effect of exchange rate changes on cash




      (639)


      590








      Net decrease in cash and cash equivalents




      (49,646)


      (808)

      Cash and cash equivalents, beginning of period




      68,979


      30,343








      Cash and cash equivalents, end of period




      $         19,333


      $         29,535



      eResearchTechnology, Inc. and Subsidiaries

      Reconciliation of GAAP to Non-GAAP Information

      (in thousands, except per share amounts)

      (unaudited)











      Three Months Ended

      Nine Months Ended











      September 30,   2010

      June 30,   2011

      September 30,   2011


      September 30,   2010

      September 30,   2011

      Net revenues


      $              45,128

      $              42,849

      $              48,083


      $               96,092

      $             132,631









      Reconciliation of GAAP to Non-GAAP gross margin:








      GAAP gross margin


      $              20,097

      $              16,045

      $              19,955


      $               47,669

      $               54,420

      Amortization of acquired intangibles and other assets


      2,451

      1,970

      1,926


      3,284

      5,774

      Non-GAAP gross margin


      $              22,548

      $              18,015

      $              21,881


      $               50,953

      $               60,194

      Non-GAAP gross margin percentage


      50.0%

      42.0%

      45.5%


      53.0%

      45.4%









      Non-GAAP gross margin percentage is calculated by dividing non-GAAP gross margin by net revenues













      Reconciliation of GAAP to Non-GAAP








          operating income:








      GAAP operating income


      $                6,589

      $                2,570

      $                5,233


      $               10,387

      $               13,157

      Amortization of acquired intangibles and other assets


      2,451

      1,970

      1,926


      3,284

      5,774

      Acquisition and integration related costs


      558

      -

      -


      5,139

      -

      Non-GAAP operating income


      $                9,598

      $                4,540

      $                7,159


      $               18,810

      $               18,931

      Non-GAAP operating income margin percentage


      21.3%

      10.6%

      14.9%


      19.6%

      14.3%









      Non-GAAP operating income margin percentage is calculated by dividing non-GAAP operating income by net revenues












      Reconciliation of GAAP to Non-GAAP net income:








      GAAP net income


      $                3,173

      $                1,781

      $                4,327


      $                 5,751

      $                 9,201

      Amortization of acquired intangibles and other assets


      2,451

      1,970

      1,926


      3,284

      5,774

      Acquisition and integration related costs


      558

      -

      -


      5,139

      -

      Income tax effect due to Non-GAAP reconciling items
       and other differences between the GAAP and
       Non-GAAP effective tax rate


      (748)

      (754)

      (611)


      (1,846)

      (1,866)

      Non-GAAP net income


      $                5,434

      $                2,997

      $                5,642


      $               12,328

      $               13,109









      Reconciliation of GAAP to Non-GAAP diluted








          net income per share:








      GAAP diluted net income per share


      $                  0.06

      $                  0.04

      $                  0.09


      $                   0.12

      $                   0.19

      Amortization of acquired intangibles and other assets


      0.05

      0.04

      0.03


      $                   0.07

      0.12

      Acquisition and integration related costs


      0.01

      -

      -


      $                   0.10

      -

      Income tax effect due to Non-GAAP reconciling items
       and other differences between the GAAP and
       Non-GAAP effective tax rate


      (0.01)

      (0.02)

      (0.01)


      $                 (0.04)

      (0.04)

      Non-GAAP diluted net income per share


      $                  0.11

      $                  0.06

      $                  0.11


      $                   0.25

      $                   0.27









      Shares used in computing diluted net income per share


      49,258

      49,330

      49,311


      49,162

      49,297

      Assumed effective tax rate - Non-GAAP


      29.0%

      27.0%

      27.0%


      29.0%

      27.0%



























      Three Months

      Year



      Ending December 31, 2011

      Ending December 31, 2011











      Low Range


      High Range


      Low Range

      High Range

      Reconciliation of GAAP to Non-GAAP








          diluted net income per share guidance:








      GAAP estimate of diluted net income per share


      $                  0.06


      $                  0.09


      $                   0.25

      $                   0.28

      Estimated effect on diluted net income per share of:








          Amortization of acquired intangibles and other assets


      0.03


      0.03


      0.15

      0.15

          Income tax effect due to Non-GAAP reconciling items
               and other differences between the GAAP and
               Non-GAAP effective tax rate


      (0.01)


      (0.01)


      (0.05)

      (0.05)

      Non-GAAP estimate of diluted net income per share


      $                  0.08


      $                  0.11


      $                   0.35

      $                   0.38









      Shares used in computing estimated diluted net income per
          share


      49,500


      49,500


      49,303

      49,303

      Effective tax rate


      27.0%


      27.0%


      35.0%

      35.0%



      SOURCE ERT

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.